Business● Low26m ago · Nov 19, 2026, 7:01 PM
Insmed may be worth $170 to $210 a share in takeover, analyst
GlobeAlert Desk · curated from Seeking Alpha Tech · global
An analyst suggests that Insmed could be valued between $170 and $210 per share in a potential takeover scenario. This provides financial market speculation regarding a company's acquisition value.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business23m agoAnthropic is now listed on Wall Street: how to invest in the AI giant's stock from ArgentinaInfobae · ArgentinaBusiness26m agoDollar price today in Dominican Republic: closing quote on November 19Infobae · ArgentinaBusiness26m agoEuro today in Bolivia: closing quote on November 19Infobae · ArgentinaBusiness30m agoAnthropic starts trading in record IPOSydney Morning Herald · Australia